SONOMA PHARMACEUTICALS INC (SNOA)

US83558L2043 - Common Stock

2.63  +0.08 (+3.14%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
12.63M
-32.21%
13.27M
5.07%
12.735M
-4.03%
15.778M
23.89%
19.794M
25.45%
EBITDA
YoY % growth
-5.48M
-82.67%
-4.2M
23.36%
-4.525M
-7.74%
N/AN/A
EBIT
YoY % growth
-5.67M
-75.54%
-4.33M
23.63%
-4.701M
-8.57%
-3.907M
16.90%
-3.029M
22.45%
Operating Margin
-44.89%-32.63%-36.91%-24.76%-15.30%
EPS
YoY % growth
N/AN/AN/A-0.68
24.72%
-1.82
-166.72%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.70
56.01%
-0.74
-329.41%
-0.63
55.05%
-0.37
36.55%
-0.40
43.62%
-0.44
41.10%
Revenue
Q2Q % growth
4.141M
31.96%
4.529M
31.70%
4.428M
30.58%
4.605M
28.67%
5.117M
23.57%
5.644M
24.62%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-948.6K
-14.01%
-1.081M
23.26%
-969K
17.39%
-591.6K
30.40%
-673.2K
29.03%
-795.6K
26.42%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.59
89.83%
-1.020.4342.16%
Q1 2025
Q2Q % growth
-1.40 -1.22-0.18-14.38%
Q3 2024
Q2Q % growth
-1.60 -4.282.6862.65%
Q2 2024
Q2Q % growth
-5.80
-1,657.58%
-4.90-0.90-18.46%
Q2 2023
Q2Q % growth
-0.33
-725.00%
%
Q1 2023
Q2Q % growth
-0.29
44.23%
%
Q3 2022
Q2Q % growth
-0.31
3.13%
%
Q2 2022
Q2Q % growth
-0.04
-166.67%
%
Q1 2022
Q2Q % growth
-0.52
-196.30%
%
Q4 2021
Q2Q % growth
-1.76
-126.86%
%
Q2 2021
Q2Q % growth
0.06
100.33%
%
Q1 2021
Q2Q % growth
0.54
-95.00%
%
Q4 2020
Q2Q % growth
-0.77
97.45%
%
Q2 2020
Q2Q % growth
-18.20
77.02%
-24.075.8724.39%
Q1 2020
Q2Q % growth
10.80
110.91%
-36.5247.32129.58%
Q4 2019
Q2Q % growth
-30.40
81.84%
-43.3512.9529.87%
Q3 2019
Q2Q % growth
-46.80
64.38%
-61.5114.7123.91%
Q2 2019
Q2Q % growth
-79.20
34.33%
-83.544.345.19%
Q1 2019
Q2Q % growth
-99.00
32.93%
-84.46-14.54-17.22%
Q4 2018
Q2Q % growth
-167.40 -107.71-59.69-55.41%
Q3 2018
Q2Q % growth
-131.40 -113.22-18.18-16.06%
Q2 2018
Q2Q % growth
-120.60 -115.67-4.93-4.26%
Q1 2018
Q2Q % growth
-147.60 -134.03-13.57-10.13%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
3.579M
31.05%
4.06M-481K-11.85%
Q1 2025
Q2Q % growth
3.391M
-1.14%
4.019M-628K-15.63%
Q4 2024
Q2Q % growth
3.439M
14.25%
4.06M-621K-15.30%
Q3 2024
Q2Q % growth
3.138M
6.73%
3.835M-697K-18.17%
Q2 2024
Q2Q % growth
2.731M
-17.99%
3.55M-819K-23.07%
Q1 2024
Q2Q % growth
3.43M
-13.82%
%
Q4 2023
Q2Q % growth
3.01M
30.87%
%
Q3 2023
Q2Q % growth
2.94M
1.38%
%
Q2 2023
Q2Q % growth
3.33M
-10.96%
%
Q1 2023
Q2Q % growth
3.98M
8.15%
%
Q4 2022
Q2Q % growth
2.3M
6.48%
%
Q3 2022
Q2Q % growth
2.9M
-41.30%
%
Q2 2022
Q2Q % growth
3.74M
-35.18%
%
Q1 2022
Q2Q % growth
3.68M
-36.22%
%
Q4 2021
Q2Q % growth
2.16M
-49.88%
%
Q3 2021
Q2Q % growth
4.94M
12.27%
%
Q2 2021
Q2Q % growth
5.77M
21.99%
%
Q1 2021
Q2Q % growth
5.77M
28.51%
%
Q4 2020
Q2Q % growth
4.31M
-1.60%
%
Q3 2020
Q2Q % growth
4.4M
-16.67%
%
Q2 2020
Q2Q % growth
4.73M
-4.25%
4.794M-64K-1.34%
Q1 2020
Q2Q % growth
4.49M
2.75%
4.794M-304K-6.34%
Q4 2019
Q2Q % growth
4.38M
19.67%
5.212M-832K-15.96%
Q3 2019
Q2Q % growth
5.28M
9.09%
5.269M11K0.21%
Q2 2019
Q2Q % growth
4.94M
14.09%
4.872M68K1.40%
Q1 2019
Q2Q % growth
4.37M
13.80%
4.291M79K1.84%
Q4 2018
Q2Q % growth
3.66M 4.578M-918K-20.05%
Q3 2018
Q2Q % growth
4.84M 4.48M360K8.04%
Q2 2018
Q2Q % growth
4.33M 4.029M301K7.47%
Q1 2018
Q2Q % growth
3.84M 3.786M54K1.43%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13.75% -527.27% 83.25% 83.25%
Revenue0% -11.74% -8.9% -8.9%